2012 annual financial data
Halozyme Therapeutics 2012 Financial results
Direct answer
Revenue was 42,325,226 USD.
Operating income was -53,625,446 USD and net income was -53,552,002 USD.
Operating cash flow was -64,329,296 USD.
Get free Halozyme Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 42,325,226 USD
- Operating income
- -53,625,446 USD
- Net income
- -53,552,002 USD
- Operating cash flow
- -64,329,296 USD
Explore related company data
View all 2012 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Halozyme Therapeutics financial years